Tirzepatide News | Live Feed & Top Stories

In the last 2 hours
 Verdict Medical Devices07:13
In the last 4 hours
 pharmaphorum05:40
Yesterday
 Evening Standard14:50 20-Jan-25
 The Nittany Turkey (Weblog)14:03 20-Jan-25
 Pharmacy Times12:40 20-Jan-25
 Pharmacy Times12:40 20-Jan-25
 Yahoo! UK & Ireland12:35 20-Jan-25
 TCTMD11:43 20-Jan-25
 i News11:14 20-Jan-25
 Medpage Today11:01 20-Jan-25
 Zacks10:02 20-Jan-25
 Hindustan Times08:26 20-Jan-25
 The Financial Express08:00 20-Jan-25
 The Financial Express03:44 20-Jan-25
 The Financial Express03:21 20-Jan-25
In the last 7 days
 Metro.co.uk12:29 19-Jan-25
 pharmaphorum07:21 19-Jan-25
 The Motley Fool04:25 19-Jan-25
 The Financial Express22:01 18-Jan-25
 The Motley Fool06:43 18-Jan-25
 The Motley Fool06:12 18-Jan-25
 Medpage Today15:17 17-Jan-25
 BioPharma Dive15:12 17-Jan-25
 TCTMD15:00 17-Jan-25
 The Motley Fool11:39 17-Jan-25
 Men's Health10:43 17-Jan-25
 Yahoo! US09:48 17-Jan-25
 The House of Commons Library blog09:39 17-Jan-25
 Yahoo! UK & Ireland06:46 17-Jan-25
 Pharmaceutical Technology17:04 16-Jan-25
 Patch12:06 16-Jan-25
 British Medical Journal11:27 16-Jan-25
 The Motley Fool03:24 16-Jan-25
 The Korea Herald21:55 15-Jan-25
 Benzinga14:42 15-Jan-25
 Zacks13:05 15-Jan-25
 JD Supra11:52 15-Jan-25
 MailOnline11:42 15-Jan-25
 Pharmacy Times08:10 15-Jan-25
 pharmaphorum08:04 15-Jan-25
 Finance in Bold07:43 15-Jan-25
 Zacks07:30 15-Jan-25
 Pharmaceutical Technology06:40 15-Jan-25
 pharmaphorum04:41 15-Jan-25
 Scrip Pharma Intelligence21:54 14-Jan-25
 Yahoo! UK & Ireland15:19 14-Jan-25
 Proactive Investors (US)14:09 14-Jan-25
 Yahoo! UK & Ireland14:08 14-Jan-25
 Proactive Investors (US)13:18 14-Jan-25
 University of Ottawa (Press Release)12:25 14-Jan-25
 Quartz11:25 14-Jan-25
 Benzinga11:16 14-Jan-25
 WSFA TV 12, Alabama10:38 14-Jan-25
 NutraIngredients-USA.com10:36 14-Jan-25
 Benzinga10:23 14-Jan-25
 The List10:10 14-Jan-25
 Daily Record10:05 14-Jan-25
 Medpage Today09:40 14-Jan-25
 PR Newswire (Press Release)08:58 14-Jan-25
 Next Avenue07:11 14-Jan-25
In the last month
 ABC15.com, Arizona16:30 13-Jan-25
 University at Buffalo13:07 13-Jan-25
 Pharmacy Times12:46 13-Jan-25
 The Nittany Turkey (Weblog)12:04 13-Jan-25
 Labiotech09:02 13-Jan-25
 GlobeNewswire (Press Release)07:08 13-Jan-25
 Regeneron Pharmaceuticals (Press Release)06:37 13-Jan-25
 pharmaphorum05:12 13-Jan-25
 Pharmaceutical Technology04:31 13-Jan-25
 New Zealand Herald21:11 10-Jan-25
 European Pharmaceutical Review18:58 10-Jan-25
 GlobeNewswire (Press Release)16:16 10-Jan-25
 Drug Target Review06:15 10-Jan-25
 Community Impact Newspaper16:18 9-Jan-25
 TCTMD15:54 9-Jan-25
 Benzinga14:16 9-Jan-25
 Manchester Evening News14:06 9-Jan-25
 PR Newswire (Press Release)10:44 9-Jan-25
 Zacks09:35 9-Jan-25
 Cornell Chronicle09:34 9-Jan-25
 Medpage Today09:26 9-Jan-25
 Benzinga09:22 9-Jan-25
 Business Wire (Press Release)08:32 9-Jan-25
 Zacks07:33 9-Jan-25
 Pharmaceutical Technology07:05 9-Jan-25
 Quartz17:31 8-Jan-25
 Business Wire (Press Release)16:09 8-Jan-25
 Pharmacy Times11:15 8-Jan-25
 NewsMax08:11 8-Jan-25
 PR Newswire (Press Release)07:10 8-Jan-25
 HealthDay06:35 8-Jan-25
 Hindustan Times05:17 8-Jan-25
 PR Newswire (Press Release)03:07 8-Jan-25
 National Institute on Drug Abuse (Press Release)19:00 7-Jan-25
 Drug Topics14:30 7-Jan-25
 HealthDay12:05 7-Jan-25
 ENDPOINTS11:34 7-Jan-25
 HealthDay10:04 7-Jan-25
 PR Newswire (Press Release)08:23 7-Jan-25
 European Pharmaceutical Manufacturer06:45 7-Jan-25
 News-Medical.Net22:11 6-Jan-25
 Yale Medicine19:32 6-Jan-25
 American Journal of Managed Care17:05 6-Jan-25
 Glasgow Evening Times14:57 6-Jan-25
 Wellbeing News12:27 6-Jan-25
 Pharmaceutical Technology06:43 6-Jan-25
 pharmaphorum05:57 6-Jan-25
 Edinburgh Evening News02:01 6-Jan-25
 Tampa Bay Times08:03 5-Jan-25
 MailOnline03:01 5-Jan-25
 Jamestown Sun07:22 4-Jan-25
 The Motley Fool06:52 4-Jan-25
 ENDPOINTS13:18 3-Jan-25
 PR Newswire (Press Release)12:52 3-Jan-25
 JD Supra12:46 3-Jan-25

      
            
      
    view more headlines
   
      
      
      
21 Jan 07:13
   

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

쮸떴눈첵

Tirzepatide

Latest News

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories